Trazodone Hydrochloride NDC 0615-8339

NDC codes

FDA NDC Directory

Product NDC (as listed)0615-8339Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00615-8339Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0615-8339-05	00615833905	15 TABLET in 1 BLISTER PACK (0615-8339-05)Marketed from Aug 23, 2023
0615-8339-39	00615833939	30 TABLET in 1 BLISTER PACK (0615-8339-39)Marketed from Jan 27, 2022

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Trazodone Hydrochloride
Generic name (nonproprietary): trazodone hydrochloride
Active ingredients: Trazodone hydrochloride — 150 mg/1
Dosage form: Tablet
Route: Oral
Labeler: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 071525
Marketing start: Mar 11, 2020
Listing expires: Dec 31, 2027
Identifiers: Product ID 0615-8339_8d918eb1-4133-4745-9afe-392ca3a699f9SPL ID 8d918eb1-4133-4745-9afe-392ca3a699f9SPL set ID 310c4b81-d2cf-4014-873d-e71d036105deRxCUI 856364, 856377UNII 6E8ZO8LRNM
Pharmacologic class: Serotonin Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400615833905 followed by a unit qualifier and the quantity

Package 00615-8339-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults. Trazodone hydrochloride tablets are a selective serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) ( 1 ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 071525

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 071525
Product	Strength	Form · route	Labeler	Product NDC
Trazodone Hydrochloride	Trazodone hydrochloride 150 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	72789-079
Trazodone Hydrochloride	Trazodone hydrochloride 150 mg/1	TabletOral	Teva Pharmaceuticals USA, Inc.	50111-450
Trazodone Hydrochloride	Trazodone hydrochloride 150 mg/1	TabletOral	AvKARE	42291-829